Vaccines are the most effective strategy to mitigate the global impact of COVID-19. However,
vaccine hesitancy is common, particularly among minorities. Guillain-Barré syndrome (GBS…

mRNA vaccines against SARS-CoV-2 are remarkably effective. Limited information exists
about the incidence of adverse events following immunization (AEFI) with their use. We …

Background Human monkeypox, a zoonosis historically endemic to West and South Africa,
has led to a worldwide outbreak driven by human-to-human transmission resulting in an …

Background The coronavirus disease 2019 (COVID-19) is a systemic entity that frequently
implies neurologic features at presentation and complications during the disease course. We …

Background and purpose Information on Guillain–Barré syndrome (GBS) as an adverse event
following immunization (AEFI) against SARS‐CoV‐2 remains scarce. We aimed to report …

Background A high proportion of coronavirus disease 2019 (COVID-19) survivors may
develop long-term cognitive impairment. We aimed to develop a multivariate causal model …

Background An intriguing feature recently unveiled in some COVID-19 patients is the “silent
hypoxemia” phenomenon, which refers to the discrepancy of subjective well-being …

Background and Objectives Information on stroke among severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccines remains scarce. We report stroke incidence as an …

Objectives Vaccination has been effective in ameliorating the impact of COVID-19. Here, we
report vaccine effectiveness (VE) of the nationally available COVID-19 vaccines in Mexico. …

Background The coronavirus disease 2019 (COVID-19) pandemic dramatically increased
the number of patients requiring treatment in an intensive care unit or invasive mechanical …